Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
about
Human herpesvirus 8--a novel human pathogenMulticentric Castleman's disease and Kaposi's sarcoma in a cyclosporin treated, HIV-1 negative patient: case reportThe Role of Gammaherpesviruses in Cancer PathogenesisKSHV: pathways to tumorigenesis and persistent infectionBlockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirusMolecular virology of Kaposi's sarcoma-associated herpesvirusViral FLICE inhibitory protein of rhesus monkey rhadinovirus inhibits apoptosis by enhancing autophagosome formationKaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin?A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage displayEarly and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells.Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.Signaling activities of gammaherpesvirus membrane proteinsExperimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses.Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseasesCellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity?How do viruses trick B cells into becoming lymphomas?Kaposi's sarcoma-associated herpesvirus ORF57 promotes escape of viral and human interleukin-6 from microRNA-mediated suppressionThe KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells.Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesisKaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesisDistribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphomaPathology of Kaposi's Sarcoma-Associated Herpesvirus InfectionHIV-associated multicentric Castleman diseaseViral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.β-HHVs and HHV-8 in Lymphoproliferative Disorders.Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.Castleman disease.Absence of T cells confers increased pulmonary arterial hypertension and vascular remodeling.Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration.Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1.Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation.Intracellular localization map of human herpesvirus 8 proteins.Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation.Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies.NF-κB as a target for oncogenic viruses.Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease.The clinical spectrum of Castleman's disease.Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation
P2860
Q24530670-08484EE3-B8AA-4ECC-B4AC-1004B782DD99Q24805204-34E8B67B-34E2-4E55-BF3C-BC421B98F1D5Q26767186-3666500F-4FF0-4BE6-89E2-1EEFC3ED414CQ27026000-B4B9427F-FB51-43AE-BB98-89E6B7C03CB6Q27486045-5132C049-05F7-492C-B77E-C92D52EF2626Q28363323-C47CDCB8-42B6-4670-82C6-9669B6071C5FQ28480552-FAEF3718-5CB4-43A0-9BA5-3943C543BC6DQ29394711-6E91C437-9EFB-4F16-870B-A39ACB122A3EQ30544892-FE3D5F81-5433-4F3D-A337-608937D1D4BDQ33254113-BE0F7FFD-35A1-4B53-A4D3-3D55A7C4AE59Q33623056-4E7C8E84-5445-47CC-B7E7-56351FE244EFQ33641552-1BA04703-4B78-4533-A25A-5DA469C127E8Q33647676-1DCC9A1D-E6F8-4D6C-A40A-A4A9F18CD264Q33822504-7E0BA18F-D329-4499-8F5C-34BB2817B325Q33825437-44782866-9EE3-41AE-B9E5-09C905452207Q33906970-09679B92-23FD-4797-9A40-1A6ACBD62FF1Q33918443-948CAFEE-EC70-4E2A-BE00-3FB27D894FFDQ34020096-52C8A450-CE12-4AF3-A0B9-26ABCF188E8BQ34742851-58D412E8-50FB-4AF3-ACC4-1ACDBA02C3EBQ35071118-7A7DD79D-4C06-4CC0-AD7E-CDE0FAD8E1BDQ35124404-93547D35-1236-4E34-A476-77E037E1B9BAQ35127940-F4C00337-7EC1-48BC-BEC5-28D04C69D51DQ35131811-BCA382AB-F34C-448F-BC44-2590B639E309Q35179783-6B17E429-FCBD-4FA4-9ED3-BF71C7FF1C76Q35226470-A1EC80F5-35BF-4CD8-AC68-A3F5A7F2EBB0Q35550033-694B9136-8CB6-4EC5-8E58-30D2F5495EF0Q35560251-1EFF3CDD-C7B3-43FC-BB3C-8F48892E36D4Q35809792-AB55EC50-4D01-4327-9EA5-98A5EA389165Q36297647-87AF1049-6C23-436F-BD4B-FBD3D063EB63Q36330527-2D1EC64D-5D1C-48E6-87CF-3976730B4489Q36364597-FE9A7A0A-2EEB-4728-9C41-EBB4AB0845E2Q36433852-A0649BA7-617D-4906-ACEF-BFE39922BB66Q36483206-BFE96166-633F-4C80-9EDD-BBC5D8905B57Q36483264-1273236B-6AA9-45E0-8520-3AED4498EEACQ36607305-66E46FB2-6650-4B77-AD39-F3EEAAC79E36Q36969847-DB61944C-56C5-4263-8CE2-3A29047D6378Q37374081-2010AD9D-ABF0-482B-B17D-6B12E0E628EAQ37405468-0ADE85EE-C26D-4052-B589-57BFC27195B3Q37509958-4ECFECA6-E460-4E11-B1A4-2E49920D605EQ37568044-EEA8E23E-CA83-4FB2-B902-9D892CDFBCB6
P2860
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Expression of a virus-derived ...... onegative Castleman's disease.
@ast
Expression of a virus-derived ...... onegative Castleman's disease.
@en
type
label
Expression of a virus-derived ...... onegative Castleman's disease.
@ast
Expression of a virus-derived ...... onegative Castleman's disease.
@en
prefLabel
Expression of a virus-derived ...... onegative Castleman's disease.
@ast
Expression of a virus-derived ...... onegative Castleman's disease.
@en
P2093
P2860
P1476
Expression of a virus-derived ...... onegative Castleman's disease.
@en
P2093
C Parravicini
M Corbellino
M Lazzarino
P2860
P304
P407
P577
1997-12-01T00:00:00Z